| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in AVTX over the last quarter tilts toward selling: insiders offloaded a net 101,317 shares worth roughly $2.0M.
Classified under Biotechnology (Health Care sector), AVTX's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 190.3K | - | - | |
| Other | 95.0K | - | - | |
| Other | 51.8K | $1.04M | - | |
| CFO | 39.9K | $651.7K | - | |
| Other | 37.0K | $725.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 1, 2026 | Doyle Mittie | Chief Medical Officer | Sale+OE | 679 | $16.00 | $10,864.00 | -15.8% | +10.7% | - | |
| Mar 16, 2026 | Doyle Mittie | Chief Medical Officer | Sale+OE | 25,492 | $16.15 | $411,606.58 | -87.6% | - | - | |
| Nov 14, 2025 | Goldman Jonathan | Director | Sale+OE | 11,367 | $14.33 | $162,936.78 | -100% | -4.7% | - | |
| Nov 13, 2024 | Almenoff June Sherie62 | Director | Buy | 1,000 | $12.75 | $12,749.50 | New | -42.8% | +9.9% | |
| Jun 27, 2023 | Armistice Capital, LLC56 | 10% Owner | Sell | 3,683,542 | $0.59 | $2,168,897.16 | -83.4% | -62.1% | -87.4% | |
| Jun 26, 2023 | Caissa Capital Management Ltd. | 10% Owner | Buy | 1,608,000 | $0.64 | $1,030,178.81 | -100% | -67.4% | -88.4% | |
| Jun 20, 2023 | Caissa Capital Management Ltd. | 10% Owner | Buy | 8,160 | $3.88 | $31,643.69 | +0.6% | -97.0% | -98.6% | |
| Jun 14, 2023 | Caissa Capital Management Ltd. | 10% Owner | Buy | 16,899 | $3.77 | $63,629.34 | +1.2% | -95.9% | -98.4% | |
| Jun 9, 2023 | Sullivan Christopher Ryan | Chief Financial Officer | Buy | 511 | $3.42 | $1,747.62 | +68.0% | -97.6% | -98.9% | |
| Jun 9, 2023 | Neil Garry Arthur | CEO And Chairman Of The Board | Buy | 4,000 | $3.42 | $13,680.00 | +43.4% | -97.6% | -98.9% |